198 related articles for article (PubMed ID: 23121976)
1. Cell-mediated immune response to epitopic MAP (multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model.
Shreewastav RK; Ali R; Uppada JB; Rao DN
Cell Immunol; 2012; 278(1-2):55-62. PubMed ID: 23121976
[TBL] [Abstract][Full Text] [Related]
2. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.
Uppada SB; Bhat AA; Sah A; Donthamshetty RN
Vaccine; 2011 Nov; 29(50):9352-60. PubMed ID: 22001881
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis.
Gupta G; Khan AA; Rao DN
Scand J Immunol; 2010 Mar; 71(3):186-98. PubMed ID: 20415784
[TBL] [Abstract][Full Text] [Related]
4. Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model.
Ali R; Naqvi RA; Kumar S; Bhat AA; Rao DN
Scand J Immunol; 2013 May; 77(5):361-71. PubMed ID: 23480362
[TBL] [Abstract][Full Text] [Related]
5. Multiple antigen peptide consisting of B- and T-cell epitopes of F1 antigen of Y. pestis showed enhanced humoral and mucosal immune response in different strains of mice.
Ali R; Kumar S; Naqvi RA; Sheikh IA; Rao DN
Int Immunopharmacol; 2013 Jan; 15(1):97-105. PubMed ID: 23174507
[TBL] [Abstract][Full Text] [Related]
6. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis.
Khan AA; Babu JP; Gupta G; Rao DN
Vaccine; 2008 Jan; 26(3):316-32. PubMed ID: 18096277
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of CD4+/CD8+ T-cell expression and IFN-γ, perforin secretion for B-T constructs of F1 and V antigens of Yersinia pestis.
Gupta G; Ali R; Khan AA; Rao DN
Int Immunopharmacol; 2012 Jan; 12(1):64-73. PubMed ID: 22094541
[TBL] [Abstract][Full Text] [Related]
8. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
[TBL] [Abstract][Full Text] [Related]
9. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
[TBL] [Abstract][Full Text] [Related]
10. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery.
Tripathi V; Chitralekha KT; Bakshi AR; Tomar D; Deshmukh RA; Baig MA; Rao DN
Vaccine; 2006 Apr; 24(16):3279-89. PubMed ID: 16476510
[TBL] [Abstract][Full Text] [Related]
11. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
Eyles JE; Butcher WA; Titball RW; Hill J
Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.
Kilgore PB; Sha J; Hendrix EK; Motin VL; Chopra AK
mBio; 2021 Dec; 12(6):e0322321. PubMed ID: 34872353
[TBL] [Abstract][Full Text] [Related]
13. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague.
Zvi A; Rotem S; Zauberman A; Elia U; Aftalion M; Bar-Haim E; Mamroud E; Cohen O
Vaccine; 2017 Oct; 35(44):5995-6006. PubMed ID: 28606812
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
[TBL] [Abstract][Full Text] [Related]
15. B and T cell epitope mapping and study the humoral and cell mediated immune response to B-T constructs of YscF antigen of Yersinia pestis.
Ali R; Kumar S; Naqvi RA; Rao DN
Comp Immunol Microbiol Infect Dis; 2013 Jul; 36(4):365-78. PubMed ID: 23465748
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
[TBL] [Abstract][Full Text] [Related]
17. Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.
Wang S; Goguen JD; Li F; Lu S
Vaccine; 2011 Sep; 29(39):6802-9. PubMed ID: 21199697
[TBL] [Abstract][Full Text] [Related]
18. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.
Elvin SJ; Williamson ED
Microb Pathog; 2004 Oct; 37(4):177-84. PubMed ID: 15458778
[TBL] [Abstract][Full Text] [Related]
19. Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells.
Do Y; Park CG; Kang YS; Park SH; Lynch RM; Lee H; Powell BS; Steinman RM
Eur J Immunol; 2008 Jan; 38(1):20-9. PubMed ID: 18081041
[TBL] [Abstract][Full Text] [Related]
20. Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of V antigen of Yersinia pestis by intranasal immunization in microparticles.
Uppada JB; Khan AA; Bhat AA; Deshmukh R; Rao DN
Med Microbiol Immunol; 2009 Nov; 198(4):247-56. PubMed ID: 19779739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
